quinazolines has been researched along with sulfadiazine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gresser, JD; McCormick, GJ; Wise, DL | 1 |
| Schmidt, LH | 1 |
| Ager, AL; Kinnamon, KE; Orchard, RW | 1 |
| Allegra, CJ; Chabner, BA; Drake, J; Kovacs, JA; Lunde, M; Masur, H; Parrillo, JE; Swan, JC | 1 |
| Allegra, CJ; Baird, B; Balis, F; Chabner, BA; Drake, JC; Lack, EE; Ogata-Arakaki, D; Shelhamer, JH; Simmons, JT; Tuazon, CU | 1 |
| Kovacs, JA; Masur, H | 1 |
| Bayles, A; Olszewski, B; Thompson, PE | 1 |
1 review(s) available for quinazolines and sulfadiazine
| Article | Year |
|---|---|
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Quinazolines; Recurrence; Sulfadiazine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1988 |
6 other study(ies) available for quinazolines and sulfadiazine
| Article | Year |
|---|---|
Sustained release of a dual antimalarial system.
Topics: Animals; Antimalarials; Delayed-Action Preparations; Drug Combinations; Female; Haplorhini; Injections, Intramuscular; Macaca mulatta; Male; Mice; Quinazolines; Sulfadiazine; Time Factors | 1979 |
Studies on the 2,4-diamino-6-substituted quinazolines. III. The capacity of sulfadiazine to enhance the activities of WR-158,122 and WR-159,412 against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmo
Topics: Animals; Aotus trivirgatus; Drug Combinations; Drug Resistance, Microbial; Female; Haplorhini; Malaria; Male; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinazolines; Sulfadiazine | 1979 |
Plasmodium berghei: combining folic acid antagonists for potentiation against malaria infections in mice.
Topics: Aminobenzoates; Animals; Antimalarials; Blood; Drug Combinations; Drug Synergism; Female; Folic Acid Antagonists; Malaria; Mice; Naphthalenesulfonates; Plasmodium berghei; Quinazolines; Sulfadiazine | 1976 |
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
Topics: Animals; Cells, Cultured; Drug Therapy, Combination; Folic Acid Antagonists; Macrophages; Mice; Mice, Inbred BALB C; Pentamidine; Pyrimethamine; Quinazolines; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal; Trimethoprim; Trimetrexate | 1987 |
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Evaluation; Drug Therapy, Combination; Female; Folic Acid Antagonists; Humans; Leucovorin; Male; Middle Aged; Pneumonia, Pneumocystis; Quinazolines; Sulfadiazine; Trimetrexate | 1987 |
PAM 1392 (2,4-diamino-6-(3,4-dichlorobenzylamino) quinazoline) as a chemotherapeutic agent: Plasmodium berghei, P. cynomolgi, P.
Topics: Animals; Antimalarials; Chagas Disease; Chick Embryo; Diet; Drug Synergism; Female; Haplorhini; Leucovorin; Malaria; Male; Mice; Plasmodium malariae; Quinazolines; Sulfadiazine; Trypanosoma | 1969 |